02334oam 2200445Ia 450 991069757590332120081024091028.0(CKB)5470000002389191(OCoLC)233049818(EXLCZ)99547000000238919120080702d2008 ua 0enguran| uuuuutxtrdacontentcrdamediacrrdacarrierTrends in statins utilization and expenditures for the U.S. civilian noninstitutionalized population, 2000 and 2005[electronic resource] /Marie N. Stagnitti[Rockville, Md.] :Medical Expenditure Panel Survey, Agency for Healthcare Research and Quality,[2008]6 unnumbered pages digital, PDF fileStatistical brief ;#205Title from title screen (viewed Sept. 12, 2008)."May 2008."Includes bibliographical references.This Statistical Brief examines trends for 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, commonly know as statins, for the years 2000 and 2005. The data included in this brief are derived from 2000 and 2005 data for the U.S. civilian noninstitutionalized population from the Household Component of the Medical Expenditure Panel Survey (MEPS-HC). The brief compares 2000 and 2005 total expenditures, total number of purchases, and total number of persons purchasing, as well as average total expenditure and average number of purchases of statins for those with one or more statin purchases.Drug utilizationEconomic aspectsUnited StatesPrescription pricingUnited StatesStatins (Cardiovascular agents)United StatesDrug utilizationEconomic aspectsPrescription pricingStatins (Cardiovascular agents)Stagnitti Marie N1386624United States.Agency for Healthcare Research and Quality.Medical Expenditure Panel Survey (U.S.)VVKVVKGPOBOOK9910697575903321Trends in statins utilization and expenditures for the U.S. civilian noninstitutionalized population, 2000 and 20053476447UNINA